Daniel J Jackson

5PUBLICATIONS
25CO-AUTHORS
Gene and molecular therapyGlycoconjugatesInfant and child healthFluid-structure interaction and aeroacoustics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Feb 25, 2026
Switching to twice-yearly depemokimab from mepolizumab/benralizumab in severe asthma: a multicenter, randomized, double-blind, phase 3A clinical trial (NIMBLE).

Geoffrey Chupp, Hiroyuki Nagase, Dirk Skowasch

|Nov 24, 2025
Human coronavirus HKU1 neutralization by glycan receptor mimicry.

Ziqi Feng, Nurgun Kose, Fernando R Moreira

|Nov 07, 2025
Dupilumab efficacy by disease severity in pediatric type 2 asthma.

Daniel J Jackson, Monika Gappa, Leonard B Bacharier

|Jul 28, 2022
Dupilumab reduced impact of severe exacerbations on lung function in patients with moderate-to-severe type 2 asthma.

Alberto Papi, Jonathan Corren, Mario Castro

Pageof 1

Frequent Collaborators

2 joint publications

Gilles Devouassoux

2 joint publications

Peter Howarth

2 joint publications

David J Jackson

2 joint publications

Dirk Skowasch